Literature DB >> 15967715

The effect of dietary sphingolipids on plasma sphingomyelin metabolism and atherosclerosis.

Zhiqiang Li1, Maria J Basterr, Tiruneh K Hailemariam, Mohammad Reza Hojjati, Shendi Lu, Jin Liu, Ruijie Liu, Hongwen Zhou, Xian-Cheng Jiang.   

Abstract

Sphingomyelin (SM) plays a very important role in cell membrane formation and plasma lipoprotein metabolism. All these functions may have an impact on atherosclerotic development. To investigate the relationship between SM metabolism and atherosclerosis, we utilized a sphingolipid-rich diet to feed LDL receptor gene knockout (LDLr KO) mice and studied lipid metabolism and atherosclerosis in the mice. After 3 months of a sphingolipid-rich diet, we found a significant increase in SM, cholesterol, and SM/phosphatidylcholine (PC) ratio (50%, P<0.001; 62%, P<0.01; and 45%, P<0.01, respectively), compared to chow fed diet. HDL-lipids were not significantly altered. Non-HDL-SM, non-HDL-C, and non-HDL-SM/non-HDL-PC ratio were significantly increased (115%, P<0.001; 106%, P<0.001; and 106%, P<0.01, respectively). FPLC confirmed the results. SDS-PAGE showed an increase of apoB48 and apoB100, but no changes of apoAI. Moreover, we found that an SM-rich diet significantly increased atherosclerotic lesion area in both root assay and en face assay, compared to chow diet (58,210+/-15,300 microm(2) vs. 9670+/-2370 microm(2), P<0.001; 5.9+/-3.1% vs. 1.1+/-0.9%, P<0.001). These results indicate that the enrichment of sphingolipids in diet has proatherogenic properties.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967715     DOI: 10.1016/j.bbalip.2005.05.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Lipidomics reveals a remarkable diversity of lipids in human plasma.

Authors:  Oswald Quehenberger; Aaron M Armando; Alex H Brown; Stephen B Milne; David S Myers; Alfred H Merrill; Sibali Bandyopadhyay; Kristin N Jones; Samuel Kelly; Rebecca L Shaner; Cameron M Sullards; Elaine Wang; Robert C Murphy; Robert M Barkley; Thomas J Leiker; Christian R H Raetz; Ziqiang Guan; Gregory M Laird; David A Six; David W Russell; Jeffrey G McDonald; Shankar Subramaniam; Eoin Fahy; Edward A Dennis
Journal:  J Lipid Res       Date:  2010-07-29       Impact factor: 5.922

2.  Selective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis.

Authors:  Yifan Fan; Fujun Shi; Jing Liu; Jibin Dong; Hai H Bui; David A Peake; Ming-Shang Kuo; Guoqing Cao; Xian-Cheng Jiang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09-02       Impact factor: 8.311

3.  Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism.

Authors:  Calvin Yeang; Shucun Qin; Kailian Chen; David Q-H Wang; Xian-Cheng Jiang
Journal:  J Lipid Res       Date:  2010-06-11       Impact factor: 5.922

4.  De Novo Sphingolipid Biosynthesis in Atherosclerosis.

Authors:  Tae-Sik Park; Shivani Devi; Amitesh Sharma; Goon-Tae Kim; Kyung-Hee Cho
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 5.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

6.  Long term effects on human plasma lipoproteins of a formulation enriched in butter milk polar lipid.

Authors:  Lena Ohlsson; Hans Burling; Ake Nilsson
Journal:  Lipids Health Dis       Date:  2009-10-16       Impact factor: 3.876

7.  Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.

Authors:  Jing Liu; Hongqi Zhang; Zhiqiang Li; Tiruneh K Hailemariam; Mahua Chakraborty; Kailiu Jiang; Daniel Qiu; Hai H Bui; David A Peake; Ming-Shang Kuo; Raj Wadgaonkar; Guoqing Cao; Xian-Cheng Jiang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-12       Impact factor: 8.311

8.  Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1.

Authors:  Charmi Shah; Guang Yang; Ian Lee; Jacek Bielawski; Yusuf A Hannun; Fahumiya Samad
Journal:  J Biol Chem       Date:  2008-03-22       Impact factor: 5.157

Review 9.  Ceramide: a common pathway for atherosclerosis?

Authors:  Jean Bismuth; Peter Lin; Qizhi Yao; Changyi Chen
Journal:  Atherosclerosis       Date:  2007-10-25       Impact factor: 5.162

Review 10.  Sphingolipids in obesity and related complications.

Authors:  Krishna M Boini; Min Xia; Saisudha Koka; Todd W B Gehr; Pin-Lan Li
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.